Search results
Gilead Beats Earnings Expectations After Rocky Quarter
Barrons.com· 7 days agoGilead said that the charge had a $3.12 per share impact on the company’s diluted earnings. In an...
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoGilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences,...
Gilead's quarterly loss is narrower than expected
Morningstar· 7 days agoGilead Sciences Inc.'s stock dipped 0.2% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected. Gilead (GILD) posted a net loss of ...
Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again
Investor's Business Daily· 6 days agoIn an interview with Investor's Business Daily, Gilead Chief Executive Daniel O'Day called the...
Gilead posts quarterly loss, revenue rises 5%
WSAU Wausau· 7 days agoBy Deena Beasley (Reuters) - Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of...